Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M8,905Revenue $M7,493Net Margin (%)9.5Altman Z-Score3.1
Enterprise Value $M12,545EPS $4.9Operating Margin %18.7Piotroski F-Score7
P/E(ttm)12.7Beneish M-Score-2.5Pre-tax Margin (%)14.9Higher ROA y-yY
Price/Book1.910-y EBITDA Growth Rate %7.1Quick Ratio1.4Cash flow > EarningsY
Price/Sales1.25-y EBITDA Growth Rate %3.6Current Ratio1.5Lower Leverage y-yY
Price/Free Cash Flow15.5y-y EBITDA Growth Rate %22.9ROA % (ttm)7.1Higher Current Ratio y-yY
Dividend Yield %2.4PEG3.5ROE % (ttm)16.0Less Shares Outstanding y-yY
Payout Ratio %30.0Shares Outstanding M143ROIC % (ttm)11.6Gross Margin Increase y-yN

Gurus Latest Trades with DGX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
DGXCharles Brandes 2015-12-31 Reduce$61.58 - $72.11
($67.4)
$ 62.42-7%Reduce -0.84%168,985
DGXChris Davis 2015-09-30 Reduce-0.2%$60.51 - $74.58
($69.9)
$ 62.42-11%Reduce -15.59%4,203,791
DGXJoel Greenblatt 2015-09-30 Add0.19%$60.51 - $74.58
($69.9)
$ 62.42-11%Add 113.30%600,031
DGXJohn Rogers 2015-09-30 Add0.09%$60.51 - $74.58
($69.9)
$ 62.42-11%Add 19.84%695,732
DGXCharles Brandes 2015-09-30 Reduce$60.51 - $74.58
($69.9)
$ 62.42-11%Reduce -1.11%170,422
DGXDavid Dreman 2015-09-30 Reduce$60.51 - $74.58
($69.9)
$ 62.42-11%Reduce -0.29%19,914
DGXT Rowe Price Equity Income Fund 2015-06-30 Sold Out -0.49%$69.89 - $79.6
($73.88)
$ 62.42-16%Sold Out0
DGXJoel Greenblatt 2015-06-30 Add0.14%$69.89 - $79.6
($73.88)
$ 62.42-16%Add 395.39%281,305
DGXJohn Rogers 2015-06-30 Add0.05%$69.89 - $79.6
($73.88)
$ 62.42-16%Add 12.52%580,555
DGXChris Davis 2015-06-30 Reduce-0.02%$69.89 - $79.6
($73.88)
$ 62.42-16%Reduce -1.74%4,980,482
DGXDavid Dreman 2015-06-30 Reduce-0.01%$69.89 - $79.6
($73.88)
$ 62.42-16%Reduce -7.34%19,971
DGXCharles Brandes 2015-06-30 Reduce$69.89 - $79.6
($73.88)
$ 62.42-16%Reduce -1.36%172,331
DGXRobert Olstein 2015-03-31 Sold Out -0.48%$66.27 - $77.69
($71.61)
$ 62.42-13%Sold Out0
DGXT Rowe Price Equity Income Fund 2015-03-31 Reduce-0.3%$66.27 - $77.69
($71.61)
$ 62.42-13%Reduce -41.67%1,750,000
DGXHOTCHKIS & WILEY 2015-03-31 Sold Out -0.23%$66.27 - $77.69
($71.61)
$ 62.42-13%Sold Out0
DGXJohn Rogers 2015-03-31 Add0.11%$66.27 - $77.69
($71.61)
$ 62.42-13%Add 33.49%515,958
DGXDavid Dreman 2015-03-31 Reduce-0.06%$66.27 - $77.69
($71.61)
$ 62.42-13%Reduce -33.54%21,554
DGXJoel Greenblatt 2015-03-31 Reduce-0.02%$66.27 - $77.69
($71.61)
$ 62.42-13%Reduce -35.63%56,784
DGXChris Davis 2015-03-31 Reduce-0.02%$66.27 - $77.69
($71.61)
$ 62.42-13%Reduce -1.68%5,068,925
DGXCharles Brandes 2015-03-31 Reduce-0.01%$66.27 - $77.69
($71.61)
$ 62.42-13%Reduce -6.12%174,714
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

DGX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


DGX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BALDWIN JOHN C MDDirector 2015-08-12Sell2,266$72-15.9view
ZIEGLER JOHN BDirector 2015-08-06Sell2,200$74.35-18.56view
PREVOZNIK MICHAEL ESVP & General Counsel 2015-03-03Sell3,261$71.16-14.91view
PREVOZNIK MICHAEL ESVP & General Counsel 2015-02-17Sell488$71.41-15.21view
GUINAN MARKSenior Vice President & CFO 2015-02-17Sell280$71.74-15.6view
STANZIONE DANIELDirector 2015-02-11Sell8,000$70.97-14.68view
PFEIFFER GARY MDirector 2015-02-04Sell8,000$72.43-16.4view
WILENSKY GAIL RDirector 2015-02-04Sell8,000$72.34-16.3view
ZIEGLER JOHN BDirector 2015-02-03Sell8,000$71.88-15.76view
BONGIORNO THOMAS FVP and Corporate Controller 2015-02-02Sell3,000$71.5-15.31view

Press Releases about DGX :

Quarterly/Annual Reports about DGX:

    News about DGX:

    Articles On GuruFocus.com
    Baron Growth Fund New Purchases Part 3 Feb 08 2016 
    Popular Guru Stocks With High, Growing Yield Feb 03 2016 
    The Best Companies of the Medical Industry – September 2015 Sep 25 2015 
    Brian Rogers Buys Occidental Petroleum, Tyco In Q2 Jul 16 2015 
    Vermillion (VRML) Ovarian Cancer Test Mega-deal; Papa Murphy's Holdings (FRSH) and Wix (WIX) Strong Mar 18 2015 
    Charles Brandes' Top Buys During Q4 Feb 11 2015 
    A Look at John Hussman's Recent Additions to His Portfolio Feb 06 2015 
    DGX: A Healthy Diagnosis Oct 08 2014 
    The Top Five Guru-Held Mid-Cap Stocks of Q2 Sep 04 2014 
    LabCorp: A Leading Independent Diagnostic Laboratory Aug 22 2014 

    More From Other Websites
    [$$] Wounded blood tester Theranos pins recovery on Arizona Feb 07 2016
    Quest Diagnostics, Inc. Earnings Analysis: Q4, 2015 By the Numbers Jan 29 2016
    Edited Transcript of DGX earnings conference call or presentation 28-Jan-16 1:30pm GMT Jan 28 2016
    Quest Diagnostics Posts In-line Q4 Earnings, Volume Low Jan 28 2016
    Quest Diagnostics Inc Earnings Call scheduled for 8:30 am ET today Jan 28 2016
    Quest Diagnostics' (DGX) Q4 Earnings, Revenues In-Line Jan 28 2016
    Quest Diagnostics Reports Fourth Quarter And Full Year 2015 Financial Results; Provides Guidance For... Jan 28 2016
    Quest Diagnostics tops 4Q profit forecasts Jan 28 2016
    Quest Diagnostics tops 4Q profit forecasts Jan 28 2016
    Q4 2015 Quest Diagnostics Inc Earnings Release - Before Market Open Jan 28 2016
    QUEST DIAGNOSTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jan 28 2016
    Quest Diagnostics Reports Fourth Quarter And Full Year 2015 Financial Results; Provides Guidance For... Jan 28 2016
    Why Q4 Earnings Beat is Dicey at Quest Diagnostics (DGX) Jan 25 2016
    Quest Diagnostics Expands Dako's PD-L1 IHC 28-8 Complementary Test to Include Melanoma Jan 25 2016
    Virgin Pulse Partners with Quest Diagnostics® to Offer Employers Best-in-Class Biometric Screening Jan 20 2016
    2015 sales in line with expectations after all planned milestones with Quest Diagnostics were met Jan 19 2016
    Quest Diagnostics To Release Fourth Quarter And Full Year 2015 Financial Results On January 28 Jan 15 2016
    Quest Diagnostics To Release Fourth Quarter And Full Year 2015 Financial Results On January 28 Jan 15 2016
    Giants Draw Blood in Quest for an Edge Jan 14 2016
    Quest CEO: We Are World's Largest Laboratory Jan 13 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK